Trade Summary

5 days ago, Van Oene Mark, serving as See Remarks at Pacific Biosciences of California, Inc. (PACB), sold 184,897 shares at $1.59 per share, for a total transaction value of $294,318.00. Following this transaction, Van Oene Mark now holds 1,742,638 shares of PACB.

This sale represents a 10.00% decrease in Van Oene Mark's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, February 17, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 19, 2026, 2 days after the trade was made.

Pacific Biosciences of California, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.